CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the first quarter ended March 31, 2026.

Multicenter, open-label study will evaluate the safety and preliminary efficacy of CK0802, a first-in-class, off-the-shelf ...

With some mindful considerations, drinking watermelon juice can be just as good for you as eating the fruit.

To car lovers, concept cars are the blood hump of any auto show, where people are drawn and excitement is generated as soon ...

BCI 2026, the annual conference of the Battery Council International (BCI), opened today in the Omni Hotel, Nashville, ...

For the past 18 years, the Kansas Hispanic Education and Development Foundation has helped hundreds of students in Wichita ...

A long-overlooked writing system from 5000 years ago is still largely undeciphered, but could mark the moment humans first ...

Cancer cells release tiny biological packages called extracellular vesicles (EVs) that help tumors grow and spread. A team ...

After centuries of mystery, scientists are edging closer to uncovering Leonardo da Vinci’s biological secrets. A massive ...

Revenue growth accelerated, margins expanded, and we continued to demonstrate operating leverage as we progress towards profitability. As a reminder, our focus in 2026 centers on three objectives: ...

Blue Ops, a division of Red Cat Holdings, is evolving its Variant family of unmanned surface vessels (USVs), with initial ...